IRIS Institutional Research Information System - OPENBS Open Archive UniBS

VALSECCHI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.754
EU - Europa 2.533
AS - Asia 2.500
SA - Sud America 445
Continente sconosciuto - Info sul continente non disponibili 213
AF - Africa 63
OC - Oceania 17
Totale 11.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.600
CN - Cina 1.020
SG - Singapore 752
PL - Polonia 487
IT - Italia 454
UA - Ucraina 419
BR - Brasile 373
DE - Germania 340
HK - Hong Kong 187
GB - Regno Unito 183
VN - Vietnam 168
FI - Finlandia 167
FR - Francia 143
IN - India 108
RU - Federazione Russa 105
CA - Canada 94
IE - Irlanda 75
TR - Turchia 69
BD - Bangladesh 37
MX - Messico 27
CZ - Repubblica Ceca 26
BE - Belgio 24
ID - Indonesia 24
SE - Svezia 21
JP - Giappone 20
SA - Arabia Saudita 20
AR - Argentina 17
IQ - Iraq 17
NL - Olanda 17
CO - Colombia 16
ZA - Sudafrica 16
AT - Austria 13
AU - Australia 13
ES - Italia 13
EC - Ecuador 12
PK - Pakistan 12
HU - Ungheria 11
NG - Nigeria 10
VE - Venezuela 9
IR - Iran 8
KE - Kenya 8
MA - Marocco 8
TH - Thailandia 7
UZ - Uzbekistan 7
EG - Egitto 6
JO - Giordania 6
PH - Filippine 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
A1 - Anonimo 5
CH - Svizzera 5
PY - Paraguay 5
AL - Albania 4
DZ - Algeria 4
EU - Europa 4
HN - Honduras 4
IL - Israele 4
JM - Giamaica 4
KG - Kirghizistan 4
LT - Lituania 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CR - Costa Rica 3
EE - Estonia 3
MU - Mauritius 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TN - Tunisia 3
AM - Armenia 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
SI - Slovenia 2
AG - Antigua e Barbuda 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
HT - Haiti 1
KW - Kuwait 1
Totale 11.310
Salva come PNG Salva come JPEG
Città #
Ashburn 687
Fairfield 487
Warsaw 483
Singapore 394
Woodbridge 371
Jacksonville 316
Ann Arbor 260
San Jose 259
Houston 241
Chandler 230
New York 195
Beijing 194
Hong Kong 187
Seattle 180
Wilmington 178
The Dalles 174
Cambridge 167
Princeton 137
Council Bluffs 116
Helsinki 112
Nanjing 98
Los Angeles 85
Dearborn 80
Dublin 75
Brescia 74
Lauterbourg 64
Munich 63
Milan 59
Istanbul 58
Shenyang 50
São Paulo 50
Jinan 49
Des Moines 47
Chicago 46
Nanchang 44
Moscow 43
Dallas 41
Ho Chi Minh City 41
Santa Clara 38
Boardman 36
Changsha 36
Tianjin 36
Columbus 35
Hebei 34
Lancaster 34
Hanoi 33
Buffalo 30
San Francisco 29
Redondo Beach 27
Shanghai 26
Orem 25
Toronto 25
Turku 24
Jiaxing 23
London 23
Rome 23
Dong Ket 20
Guangzhou 19
Phoenix 19
San Diego 19
Atlanta 18
Brussels 18
Montreal 18
Zhengzhou 18
Ningbo 17
Brooklyn 16
Chennai 16
Denver 16
Lanzhou 16
Tokyo 16
Brno 15
Manchester 15
Washington 15
Haikou 13
Frankfurt am Main 12
Norwalk 12
Hangzhou 11
Mexico City 11
Taizhou 11
Verona 11
Abuja 10
Boston 10
New Delhi 10
Olomouc 10
Charlotte 9
Jakarta 9
Kunming 9
Orange 9
Rio de Janeiro 9
San Mateo 9
Vienna 9
Belo Horizonte 8
Hefei 8
Johannesburg 8
North Bergen 8
Salvador 8
Stockholm 8
Taiyuan 8
Trieste 8
Brasília 7
Totale 7.518
Salva come PNG Salva come JPEG
Nome #
Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways 333
New Copy Number Variations in Schizophrenia 329
Farmacoterapia antipsicotica e disturbi cognitivi. 256
The impairment of GABAergic pathway as one of the driver forces in the etiopathogenesis of schizophrenia: evidence from functional studies and gene-set enrichment analyses 248
A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme 222
A randomized, flexible-dose, quasi-naturalistic comparison of quetiapine, risperidone, and olanzapine in the short-term treatment of schizophrenia: The QUERISOLA trial. 214
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 209
Comparison of quetiapine, olanzapine and risperidone in schizophrenia. 207
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 207
Looking through autistic features in schizophrenia using the PANSS Autism Severity Score (PAUSS) 203
Factors Associated With Response and Resistance to Cognitive Remediation in Schizophrenia: A Critical Review 197
The role of the cytochine network in schizophrenia: an overview. 196
Psychomotor agitation in subjects hospitalized for an acute exacerbation of Schizophrenia 195
Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia 193
-G308A tumor necrosis factor alpha functional polymorphism and schizophrenia risk: Meta-analysis plus association study 193
Analysis of Copy Number Variations in Schizophrenia Italian Patients 192
Comparison of quetiapine (‘Seroquel’), olanzapine and risperidone in a randomized study in patients with schizophrenia. 191
Interim results of a randomised, rater-blinded study comparing quetiapine, olanzapine and risperidone in patients with schizophrenia. 190
Comparison of Quetiapine, Olanzapine, and Risperidone in Patients With Schizophrenia: Interim Results of a Randomised, Rater-blinded Study. 186
Effectiveness of Cognitive Remediation in Early Versus Chronic Schizophrenia: A Preliminary Report 185
A genome-wide pharmacogenomic study of patients with schizophrenia suggests that GRM7 mediates the effects of risperidone on positive symptoms 175
Relationship of IQ to neuropsychological tasks involving prefrontal cortex in schizophrenia. 174
At-risk gambling in patients with severe mental illness. Prevalence and associated features. 172
Psychopharmacological treatment of cognitive deficits in Schizophrenia and mood disorders 170
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 169
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis 169
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study 167
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 166
Well-being in patients with schizophrenia, mood and personality disorders attending psychiatric services in the community. A controlled study 165
Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1 genes. 155
A multimodal imaging study of never-medicated adults with schizophrenia 155
Patterns of Brain Structural Changes in First-Contact, Antipsychotic Drug-Naive Patients with Schizophrenia. 155
Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates 154
Quetiapine in hospitalized patients with schizophrenia refractory to treatment with first-generation antipsychotics: a 4-week, flexible-dose, single-blind, exploratory, pilot trial. 153
Comparison of quetiapine, olanzapine and risperidone in a randomized study in patients with schizophrenia. 153
Additional Evidence for White Matter Damage in Never-Medicated Adults with Schizophrenia and Schizophreniform Disorder 152
Manuale di clinica e riabilitazione psichiatrica. Dalle conoscenze teoriche alla pratica dei servizi di salute mentale. Vol. 2: Riabilitazione psichiatrica 149
Association study between schizophrenia and the AMPA genes GRIA1, GRIA2 AND GRIA4 147
Negative symptom severity at discharge from an index hospitalization and subsequent use of psychiatric care resources: A retrospective 1-year follow-up study on 450 patients with schizophrenia spectrum disorders 147
Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report. 146
New Copy Number Variations in Schizophrenia Italian Patients 145
Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients 145
Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia: a pilot case-control association study in an Italian sample 144
Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia. 143
Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients 143
Cerebrovascular accidents in elderly people treated with antipsychotic drugs. A systematic review 141
The factor structure analysis for the positive and negative syndrome scale (PANSS) in pharmacogenetics and pharmacogenomics studies. 138
Detection of high level of autozygosity in a group of Italian schizophrenia patients 137
Immediate and 8-Month Impact of a Medical Educational Course for General Practitioners on Knowledge About Schizophrenia and Its Treatment: Results of a 3-Phase Study From Brescia, Italy. 135
Variables Associated With General Practitioners' Knowledge About and Diagnostic Skills for Schizophrenia 135
Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review 134
Mitochondrial DNA haplogroups and age at onset of schizophrenia 134
Reduced fractional anisotropy of corpus callosum in first-contact, antipsychotic drug-naive patients with schizophrenia. 132
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 131
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 131
Panic disorder with and without comorbidity: data on epidemiology, course and treatment outcome. 125
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 125
Study of the genetic architecture behind mood disorders by whole exome sequencing on a large Italian pedigree 119
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 119
Genome-Wide pharmacogenomics analysis of early antipsychotic (risperidone) response in patients with schizophrenia 118
Implementing cognitive rehabilitation interventions for schizophrenia patients in mental health services: Focus on Integrated Psychological Therapy (IPT) 118
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 117
Esperienze di switch a cariprazina in pazienti affetti da schizofrenia con ricorrenze 115
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 114
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 109
A miR-137–Related Biological Pathway of Risk for Schizophrenia Is Associated With Human Brain Emotion Processing 104
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 104
Whole exome sequencing of schizophrenia patients with high level of autozygosity. 99
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 97
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 87
La comorbidità per uso di sostanze nei disturbi psicotici e nella schizofrenia. 86
Paliperidone palmitate in short- and long-term treatment of schizophrenia 82
THE FACTOR STRUCTURE FOR THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) IN PHARMACOGENETICS: 102T/C 5-HT2A POLYMORPHISM AND RESPONSE TO RISPERIDONE 80
Totale 11.525
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022412 0 0 0 32 7 23 27 33 28 58 56 148
2022/2023639 86 9 6 68 46 176 4 67 96 11 40 30
2023/2024777 41 14 70 82 46 196 31 21 119 29 18 110
2024/20251.344 19 30 15 171 154 129 96 52 133 82 272 191
2025/20262.766 263 354 212 421 322 220 388 99 117 243 79 48
2026/2027891 97 137 240 417 0 0 0 0 0 0 0 0
Totale 11.525